Skip to Content

'
Vikas Kundra, M.D., Ph.D.

Present Title & Affiliation

Primary Appointment

Professor, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Director Molecular Imaging, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Professor, Department of Cancer Systems Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX

Bio Statement

Doctor Vikas Kundra, M.D., Ph.D. is a Professor and Director of Molecular Imaging in the Department of Radiology, U.T.- M.D. Anderson Cancer Center and has a joint appointment in the Department of Cancer Systems Imaging. He received his M.D. and Ph.D. from Harvard University and completed his training at Harvard Medical School’s Brigham and Women’s Hospital.

He is a Fellow of the Society of Body Computed Tomography-Magnetic Resonance Imaging and a Distinguished Investigator of the Academy of Radiology Research. In addition to his multiple clinical and basic/translational science papers Dr. Kundra is grant funded. He is and/or has been a principal investigator, co-PI or collaborator on several grants including from the National Institutes of Health, Department of Energy and Alliance of Nanohealth. In addition to being grant funded, Dr. Kundra is patented and has pending patents that include: Fusion Proteins Based on Somatostatin Receptors (2002) and Methods and Composition Related to In Vivo Imaging of Gene Expression (2005).

Research Interests

Imaging of: Gene Expression, Gene Therapy and Responsive Therapy

Clinical Interests

MR CT

Abdominal II

GU Imaging

Prostrate Imaging 

Education & Training

Degree-Granting Education

1995 Harvard Medical School, Harvard University, Boston, MA, MD, with Honors in a Special Field, Medicine
1995 Harvard Medical School, Harvard University, Boston, MA, PHD, with Honors in a Special Field, Program in Cell and Developmental Biology
1987 Loyola College of Baltimore, Baltimore, MD, BS, Biology

Postgraduate Training

2000-2001 Clinical and Research Fellowship, Brigham and Women's Hospital, Department of Radiology, Boston, MA
1996-2000 Clinical and Research Residency, Brigham and Women's Hospital, Department of Radiology, Boston, MA
1995-1996 Research Fellowship, Brigham and Women's Hospital, Department of Radiology, Boston, MA

Board Certifications

2000 The American Board of Radiology

Experience/Service

Academic Appointments

Associate Professor, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007-2012

Administrative Appointments/Responsibilities

Section Chief, Body Imaging, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010-2012

Honors and Awards

2014 Distinguished Investigator Award, Academy of Radiology Research
2014 Study Section, Department of Energy
2014 Visiting Professor, AC Camargo
2013 Invited speaker to AC Camargo 60 year anniversary, AC Camargo
2013 Education Exhibit Award, Radiological Society of North America
2012 Integrated Nuclear Medicine Research Training projects of Excellence Review, Department of Energy Office of Science
2012 Leading Doctors in the World
2010 Medical Imaging Expert Panel, NASA
2009-present Fellow, Society of Computed Body Tomography/Magnetic Resonance (SCBT/MR)
2009-present NIH Study Section, National Institutes of Health
2009 Marquis Who's Who in America
2008 Imaging Expert for Panel - Stress and Cancer, NIH/NCI
2005 Who's Who in Executives and Professionals, National Register
2004 Who's Who in Executives and Professionals, National Register
2000 Brigham and Women's Hospital Annual Research Award for Outstanding Research by a Radiology Resident, Department of Radiology, Harvard Medical School
2000 Dodd Research Award, Society of Gastrointestinal Radiology
1997 Brigham and Women's Hospital Annual Research Award for Outstanding Research by a Radiology Resident, Department of Radiology, Harvard Medical School
1997 CREF Research Award
1997 Introduction to Research Program, Radiologic Society of North America
1997 Mallinkrodt Research Fellowship/Grant, Society of Nuclear Medicine
1995 M.D. with Honors, Harvard Medical School
1995 Ph.D., Harvard Medical School
1993 Proctor and Gamble Professional Opportunity Award for Outstanding Abstract in Cell and General Physiology, American Physiological Society
1987-1988 Fulbright Scholarship to the United Kingdom
1987 Summer Scientist Training, National Institutes of Health
1986 Biology Honor Society, Beta-Beta-Beta
1986 Jesuit Honor Society, Alpha-Sigma-Nu
1986 Outstanding Achievement in Organic Chemistry Award
1986 Who's Who in American Universities
1984-1987 Presidential Scholarship II, Loyola College

Selected Publications

Peer-Reviewed Original Research Articles

1. Bhosale P, Ma J, Iyer R, Ramalingam P, Wei W, Soliman P, Frumovitz M, Kundra V. Feasibility of a reduced field-of-view diffusion-weighted (rFOV) sequence in assessment of myometrial invasion in patients with clinical FIGO stage I endometrial cancer. J Magn Reson Imaging. e-Pub 7/2015. PMID: 26185031.
2. Tan CH, Paul Hobbs B, Wei W, Kundra V. Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis. AJR Am J Roentgenol 204(4):W439-48, 4/2015. PMID: 25794093.
3. Pan Y, Rhea P, Tan L, Cartwright C, Lee HJ, Ravoori MK, Addington C, Gagea M, Kundra V, Kim SJ, Newman RA, Yang P. PBI-05204, a supercritical CO2 extract of Nerium oleander, inhibits growth of human pancreatic cancer via targeting the PI3K/mTOR pathway. Invest New Drugs 33(2):271-9, 4/2015. e-Pub 12/2014. PMCID: PMC4387257.
4. Bahmani B, Guerrero Y, Bacon D, Kundra V, Vullev VI, Anvari B. Functionalized polymeric nanoparticles loaded with indocyanine green as theranostic materials for targeted molecular near infrared fluorescence imaging and photothermal destruction of ovarian cancer cells. Lasers Surg Med 46(7):582-92, 9/2014. e-Pub 6/2014. PMID: 24961210.
5. Wan X, Corn PG, Yang J, Palanisamy N, Starbuck MW, Efstathiou E, Tapia EM, Zurita AJ, Aparicio A, Ravoori MK, Vazquez ES, Robinson DR, Wu YM, Cao X, Iyer MK, McKeehan W, Kundra V, Wang F, Troncoso P, Chinnaiyan AM, Logothetis CJ, Navone NM. Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases. Sci Transl Med 6(252):252ra122, 9/2014. PMID: 25186177.
6. Guimaraes M, Bitencourt A, Marchiori E, Chojniak R, Gross JL, Kundra V. Imaging acute complications in cancer patients: what should be evaluated in the emergency setting? Cancer Imaging 14(18), 4/2014.
7. Ganeshan D, Szklaruk J, Kundra V, Kaseb A, Rashid A, Elsayes KM, Elsayes K. Imaging features of fibrolamellar hepatocellular carcinoma. AJR Am J Roentgenol 202(3):544-552, 3/2014. PMID: 24555590.
8. Ganeshan D, Morani A, Ladha H, Bathala T, Kang H, Gupta S, Lalwani N, Kundra V. Staging, surveillance, and evaluation of response to therapy in renal cell carcinoma: role of MDCT. Abdom Imaging 39(1):66-85, 2/2014. e-Pub 9/2013. PMID: 24077815.
9. Ganeshan D, Bhosale P, Yang T, Kundra V. Imaging features of carcinoid tumors of the gastrointestinal tract. AJR Am J Roentgenol 201(4):773-786, 10/2013. PMID: 24059366.
10. Han L, Ravoori M, Wu G, Sakai R, Yan S, Singh S, Xu K, Roth JA, Ji L, Kundra V. Somatostatin receptor type 2-based reporter expression after plasmid-based in vivo gene delivery to non-small cell lung cancer. Mol Imaging 12(0):1-10, 10/2013. PMCID: PMC4103180.
11. Costelloe CM, Madewell JE, Kundra V, Harrell RK, Bassett RL, Ma J. Conspicuity of bone metastases on fast Dixon-based multisequence whole-body MRI: Clinical utility per sequence. Magn Reson Imaging 31(5):669-675, 6/2013. e-Pub 1/2013. PMCID: PMC3648589.
12. Bhosale P, Shah A, Wei W, Varadhachary G, Johnson V, Shah V, Kundra V. Carcinoid tumours: predicting the location of the primary neoplasm based on the sites of metastases. Eur Radiol 23(2):400-407, 2/2013. e-Pub 8/2012. PMID: 22932740.
13. Ravoori MK, Han L, Singh SP, Dixon K, Duggal J, Liu P, Uthamanthil R, Gupta S, Wright KC, Kundra V. Correction: Noninvasive Assessment of Gene Transfer and Expression by In Vivo Functional and Morphologic Imaging in a Rabbit Tumor Model. PLoS One 8(10), 2013. e-Pub 10/2013. PMCID: PMC3792172.
14. Ravoori MK, Han L, Singh SP, Dixon K, Duggal J, Liu P, Uthamanthil R, Gupta S, Wright KC, Kundra V. Noninvasive assessment of gene transfer and expression by in vivo functional and morphologic imaging in a rabbit tumor model. PLoS One 8(6):e62371, 2013. e-Pub 6/2013. PMCID: PMC3677885.
15. Pecot CV, Rupaimoole R, Yang D, Akbani R, Ivan C, Lu C, Wu S, Han HD, Shah MY, Rodriguez-Aguayo C, Bottsford-Miller J, Liu Y, Kim SB, Unruh A, Gonzalez-Villasana V, Huang L, Zand B, Moreno-Smith M, Mangala LS, Taylor M, Dalton HJ, Sehgal V, Wen Y, Kang Y, Baggerly KA, Lee JS, Ram PT, Ravoori MK, Kundra V, Zhang X, Ali-Fehmi R, Gonzalez-Angulo AM, Massion PP, Calin GA, Lopez-Berestein G, Zhang W, Sood AK. Tumour angiogenesis regulation by the miR-200 family. Nat Commun 4:2427, 2013. PMCID: PMC3904438.
16. Ravoori M, Duggal J, Gagea M, Han L, Singh S, Liu P, Wei W, Ragan DK, Bankson JA, Ma J, Kundra V. Visualizing the prostate gland by MR imaging in young and old mice. PLoS One 8(3):e55746, 2013. e-Pub 3/2013. PMCID: PMC3585879.
17. Ganeshan D, Bhosale P, Kundra V. Current update on cytogenetics, taxonomy, diagnosis, and management of adrenocortical carcinoma: what radiologists should know. AJR Am J Roentgenol 199(6):1283-1293, 12/2012. PMID: 23169720.
18. Tan CH, Wei W, Johnson V, Kundra V. Diffusion-weighted MRI in the detection of prostate cancer: meta-analysis. AJR Am J Roentgenol 199(4):822-829, 10/2012. PMCID: PMC3888871.
19. Fu S, Hennessy BT, Ng CS, Ju Z, Coombes KR, Wolf JK, Sood AK, Levenback CF, Coleman RL, Kavanagh JJ, Gershenson DM, Markman M, Dice K, Howard A, Li J, Li Y, Stemke-Hale K, Dyer M, Atkinson E, Jackson E, Kundra V, Kurzrock R, Bast RC, Mills GB. Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer. Gynecol Oncol 126(1):47-53, 7/2012. e-Pub 4/2012. PMCID: PMC3738300.
20. Ng CS, Waterton JC, Kundra V, Brammer D, Ravoori M, Han L, Wei W, Klumpp S, Johnson VE, Jackson EF. Reproducibility and comparison of DCE-MRI and DCE-CT perfusion parameters in a rat tumor model. Technol Cancer Res Treat 11(3):279-288, 6/2012. e-Pub 3/2012. PMID: 22417064.
21. Wan X, Li ZG, Yingling JM, Yang J, Starbuck MW, Ravoori MK, Kundra V, Vazquez E, Navone NM. Effect of transforming growth factor beta (TGF-ß) receptor I kinase inhibitor on prostate cancer bone growth. Bone 50(3):695-703, 3/2012. e-Pub 12/2011. PMCID: PMC3278589.
22. Costelloe CM, Kundra V, Ma J, Chasen BA, Rohren EM, Bassett RL, Madewell JE. Fast dixon whole-body MRI for detecting distant cancer metastasis: a preliminary clinical study. J Magn Reson Imaging 35(2):399-408, 2/2012. e-Pub 10/2011. PMCID: PMC3265627.
23. Le O, Roy A, Silverman PM, Kundra V. Common and uncommon adult unilateral renal masses other than renal cell carcinoma. Cancer Imaging 12:194-204, 2012. e-Pub 5/2012. PMCID: PMC3392784.
24. Roy A, Le O, Silverman PM, Kundra V. Common and uncommon bilateral adult renal masses. Cancer Imaging 12:205-211, 2012. e-Pub 5/2012. PMCID: PMC3390750.
25. Cheong JH, Park ES, Liang J, Dennison JB, Tsavachidou D, Nguyen-Charles C, Wa Cheng K, Hall H, Zhang D, Lu Y, Ravoori M, Kundra V, Ajani J, Lee JS, Ki Hong W, Mills GB. Dual inhibition of tumor energy pathway by 2-deoxy glucose and metformin is effective against a broad spectrum of preclinical cancer models. Mol Cancer Ther 10(12):2350-2362, 12/2011. e-Pub 10/2011. PMCID: PMC3237863.
26. Coleman RL, Duska LR, Ramirez PT, Heymach JV, Kamat AA, Modesitt SC, Schmeler KM, Iyer RB, Garcia ME, Miller DL, Jackson EF, Ng CS, Kundra V, Jaffe R, Sood AK. Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer. Lancet Oncol 12(12):1109-1117, 11/2011. e-Pub 10/2011. PMCID: PMC3444811.
27. Tamm EP, Rong XJ, Cody DD, Ernst RD, Fitzgerald NE, Kundra V. Quality initiatives: CT radiation dose reduction: how to implement change without sacrificing diagnostic quality. Radiographics 31(7):1823-32, Nov-Dec, 11/2011. e-Pub 10/2011. PMID: 21969662.
28. Gupta S, Wright KC, Ensor J, Van Pelt CS, Dixon KA, Kundra V. Hepatic arterial embolization with doxorubicin-loaded superabsorbent polymer microspheres in a rabbit liver tumor model. Cardiovasc Intervent Radiol 34(5):1021-1030, 10/2011. e-Pub 4/2011. PMID: 21479746.
29. Wright KC, Ravoori MK, Dixon KA, Han L, Singh SP, Liu P, Gupta S, Johnson VE, Kan Z, Kundra V. Perfusion CT assessment of tissue hemodynamics following hepatic arterial infusion of increasing doses of angiotensin II in a rabbit liver tumor model. Radiology 260(3):718-726, 9/2011. e-Pub 6/2011. PMCID: PMC3157000.
30. Tan CH, Wang J, Kundra V. Diffusion weighted imaging in prostate cancer. Eur Radiol 21(3):593-603, 3/2011. e-Pub 10/2010. PMID: 20936413.
31. Singh SP, Han L, Murali R, Solis L, Roth J, Ji L, Wistuba I, Kundra V. SSTR2-based reporters for assessing gene transfer into non-small cell lung cancer: evaluation using an intrathoracic mouse model. Hum Gene Ther 22(1):55-64, 1/2011. e-Pub 12/2010. PMCID: PMC3025187.
32. Bhosale P, Kwek JW, Iyer R, Wei W, Bassett R, Kundra V. Follow-up of known carcinoid liver metastases: Is respiratory-gated T2 fast spin-echo enough? Neuroendocrinology 93(4):241-248, 2011. e-Pub 4/2011. PMID: 21474918.
33. Perin EC, Tian M, Marini FC, Silva GV, Zheng Y, Baimbridge F, Quan X, Fernandes MR, Gahremanpour A, Young D, Paolillo V, Mukhopadhyay U, Borne AT, Uthamanthil R, Brammer D, Jackson J, Decker WK, Najjar AM, Thomas MW, Volgin A, Rabinovich B, Soghomonyan S, Jeong HJ, Rios JM, Steiner D, Robinson S, Mawlawi O, Pan T, Stafford J, Kundra V, Li C, Alauddin MM, Willerson JT, Shpall E, Gelovani JG. Imaging long-term fate of intramyocardially implanted mesenchymal stem cells in a porcine myocardial infarction model. PLoS One 6(9):e22949, 2011. e-Pub 9/2011. PMCID: PMC3164664.
34. Harris DM, Hazan-Haley I, Coombes K, Bueso-Ramos C, Liu J, Liu Z, Li P, Ravoori M, Abruzzo L, Han L, Singh S, Sun M, Kundra V, Kurzrock R, Estrov Z. Transformation of human mesenchymal cells and skin fibroblasts into hematopoietic cells. PLoS One 6(6):e21250, 2011. e-Pub 6/2011. PMCID: PMC3120836.
35. Lu C, Han HD, Mangala LS, Ali-Fehmi R, Newton CS, Ozbun L, Armaiz-Pena GN, Hu W, Stone RL, Munkarah A, Ravoori MK, Shahzad MM, Lee JW, Mora E, Langley RR, Carroll AR, Matsuo K, Spannuth WA, Schmandt R, Jennings NB, Goodman BW, Jaffe RB, Nick AM, Kim HS, Guven EO, Chen YH, Li LY, Hsu MC, Coleman RL, Calin GA, Denkbas EB, Lim JY, Lee JS, Kundra V, Birrer MJ, Hung MC, Lopez-Berestein G, Sood AK. Regulation of tumor angiogenesis by EZH2. Cancer Cell 18(2):185-197, 8/2010. PMCID: PMC2923653.
36. Le-Petross H, Kundra V, Szklaruk J, Wei W, Hortobagyi GN, Ma J. Fast three-dimensional dual echo dixon technique improves fat suppression in breast MRI. J Magn Reson Imaging 31(4):889-894, 4/2010. PMID: 20373433.
37. Ravoori M, Czaplinska AJ, Sikes C, Han L, Johnson EM, Qiao W, Ng C, Cody DD, Murphy WA, Do KA, Navone NM, Kundra V. Quantification of mineralized bone response to prostate cancer by noninvasive in vivo microCT and non-destructive ex vivo microCT and DXA in a mouse model. PLoS One 5(3):e9854, 2010. e-Pub 3/2010. PMCID: PMC2847943.
38. Singh SP, Yang D, Ravoori M, Han L, Kundra V. In vivo functional and anatomic imaging for assessment of in vivo gene transfer. Radiology 252(3):763-771, 9/2009. e-Pub 7/2009. PMCID: PMC2734889.
39. Ma J, Costelloe CM, Madewell JE, Hortobagyi GN, Green MC, Cao G, Sun F, Kundra V. Fast Dixon-based multi-sequence and multi-planar MRI for whole body detection of cancer metastases. J Magn Reson Imaging 29(5):1154-1162, 5/2009. PMID: 19388121.
40. Rampurwala M, Ravoori MK, Wei W, Johnson VE, Vikram R, Kundra V. Visualization and quantification of intraperitoneal tumors by in vivo computed tomography using negative contrast enhancement strategy in a mouse model of ovarian cancer. Transl Oncol 2(2):96-106, 5/2009. PMCID: PMC2670577.
41. Gnjatic S, Altorki NK, Tang DN, Tu SM, Kundra V, Ritter G, Old LJ, Logothetis CJ, Sharma P. NY-ESO-1 DNA vaccine induces T-cell responses that are suppressed by regulatory T cells. Clin Cancer Res 15(6):2130-2139, 3/2009. e-Pub 3/2009. PMID: 19276258.
42. Ghaghada KB, Ravoori M, Sabapathy D, Bankson J, Kundra V, Annapragada A. New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging. PLoS One 4(10):e7628, 2009. e-Pub 10/2009. PMCID: PMC2764087.
43. Li ZG, Mathew P, Yang J, Starbuck MW, Zurita AJ, Liu J, Sikes C, Multani AS, Efstathiou E, Lopez A, Wang J, Fanning TV, Prieto VG, Kundra V, Vazquez ES, Troncoso P, Raymond AK, Logothetis CJ, Lin SH, Maity S, Navone NM. Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms. J Clin Invest 118(8):2697-2710, 8/2008. PMCID: PMC2447924.
44. Garlich JR, De P, Dey N, Su JD, Peng X, Miller A, Murali R, Lu Y, Mills GB, Kundra V, Shu HK, Peng Q, Durden DL. A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activity (Kundra lab images on the journal cover page). Cancer Res 68(1):206-215, 1/2008. PMID: 18172313.
45. Bankson JA, Ji L, Ravoori M, Han L, Kundra V. Echo-planar imaging for MRI evaluation of intrathoracic tumors in murine models of lung cancer. J Magn Reson Imaging 27(1):57-62, 1/2008. PMID: 18058933.
46. Hennessy BT, Lu Y, Poradosu E, Yu Q, Yu S, Hall H, Carey MS, Ravoori M, Gonzalez-Angulo AM, Birch R, Henderson IC, Kundra V, Mills GB. Pharmacodynamic markers of perifosine efficacy. Clin Cancer Res 13(24):7421-7431, 12/2007. PMID: 18094426.
47. Han L, Yang D, Kundra V. Signaling can be uncoupled from imaging of the somatostatin receptor type 2. Mol Imaging 6(6):427-437, Nov-Dec, 11/2007. PMID: 18053413.
48. Kim TJ, Ravoori M, Landen CN, Kamat AA, Han LY, Lu C, Lin YG, Merritt WM, Jennings N, Spannuth WA, Langley R, Gershenson DM, Coleman RL, Kundra V, Sood AK. Antitumor and antivascular effects of AVE8062 in ovarian carcinoma. Cancer Res 67(19):9337-9345, 10/2007. PMID: 17909042.
49. Kundra V, Silverman PM, Matin SF, Choi H. Imaging in oncology from the University of Texas M. D. Anderson Cancer Center: diagnosis, staging, and surveillance of prostate cancer. AJR Am J Roentgenol 189(4):830-844, 10/2007. PMID: 17885053.
50. Ramirez MS, Ragan DK, Kundra V, Bankson JA. Feasibility of multiple-mouse dynamic contrast-enhanced MRI. Magn Reson Med 58(3):610-615, 9/2007. PMID: 17763350.
51. Auzenne E, Ghosh SC, Khodadadian M, Rivera B, Farquhar D, Price RE, Ravoori M, Kundra V, Freedman RS, Klostergaard J. Hyaluronic acid-paclitaxel: antitumor efficacy against CD44(+) human ovarian carcinoma xenografts. Neoplasia 9(6):479-486, 6/2007. PMCID: PMC1899257.
52. Kundra V, Ng CS, Ma J, Bankson JA, Price RE, Cody DD, Do KA, Han L, Navone NM. In vivo imaging of prostate cancer involving bone in a mouse model. Prostate 67(1):50-60, 1/2007. PMID: 17031813.
53. Ueda K, Kawashima H, Ohtani S, Deng WG, Ravoori M, Bankson J, Gao B, Girard L, Minna JD, Roth JA, Kundra V, Ji L. The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatin-induced resistance in human non-small-cell lung cancer cells (Kundra lab images on the journal cover page). Cancer Res 66(19):9682-9690, 10/2006. PMID: 17018626.
54. Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori M, Merritt WM, Lin YG, Mangala LS, Kim TJ, Coleman RL, Landen CN, Li Y, Felix E, Sanguino AM, Newman RA, Lloyd M, Gershenson DM, Kundra V, Lopez-Berestein G, Lutgendorf SK, Cole SW, Sood AK. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 12(8):939-944, 8/2006. e-Pub 7/2006. PMID: 16862152.
55. Visentin B, Vekich JA, Sibbald BJ, Cavalli AL, Moreno KM, Matteo RG, Garland WA, Lu Y, Yu S, Hall HS, Kundra V, Mills GB, Sabbadini RA. Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell 9(3):225-238, 3/2006. PMID: 16530706.
56. Sood A, Lu C, Jennings N, Armaiz-Pena G, Bankson J, Ravoori M, Merritt W, Lin Y, Mangala S, Tae JK, Coleman R, Landen C, Li Y, Felix E, Newman R, Lloyd M, Gershenson D, Kundra V, Lopez-Bernstein G, Cole S, Arevalo J, Takahashi R, Lutgendorf S. Stress and the spread of ovarian cancer in mice. Cancer Biol Ther 5(8):893-896, 2006.
57. Yang D, Han L, Kundra V. Exogenous gene expression in tumors: noninvasive quantification with functional and anatomic imaging in a mouse model. Radiology 235(3):950-958, 6/2005. PMID: 15914480.
58. Kundra V, Krane JF, Nikolaidis P, Green DS, Zou KH, Tuncali K, Vansonnenberg E, Silverman SG. Telomerase activity predicts malignancy in percutaneous image-guided needle biopsy specimens of the abdomen and pelvis. Radiology 234(3):941-947, 3/2005. PMID: 15734943.
59. Kundra V, Silverman PM. Impact of multislice CT on imaging of acute abdominal disease. Radiol Clin North Am 41(6):1083-1093, 11/2003. PMID: 14661659.
60. Kundra V, Silverman PM. Imaging in the diagnosis, staging, and follow-up of cancer of the urinary bladder. AJR Am J Roentgenol 180(4):1045-1054, 4/2003. PMID: 12646453.
61. Kundra V, Mannting F, Jones AG, Kassis AI. Noninvasive monitoring of somatostatin receptor type 2 chimeric gene transfer. J Nucl Med 43(3):406-412, 3/2002. PMID: 11884502.
62. Blatch GL, Lässle M, Zetter BR, Kundra V. Isolation of a mouse cDNA encoding mSTI1, a stress-inducible protein containing the TPR motif. Gene 194(2):277-282, 7/1997. PMID: 9272871.
63. Lässle M, Blatch GL, Kundra V, Takatori T, Zetter BR. Stress-inducible, murine protein mSTI1. Characterization of binding domains for heat shock proteins and in vitro phosphorylation by different kinases. J Biol Chem 272(3):1876-1884, 1/1997. PMID: 8999875.
64. Kundra V, Anand-Apte B, Feig LA, Zetter BR. The chemotactic response to PDGF-BB: evidence of a role for Ras. J Cell Biol 130(3):725-731, 8/1995. PMCID: PMC2120528.
65. Kundra V, Soker S, Zetter BR. Excess early signaling activity inhibits cellular chemotaxis toward PDGF-BB. Oncogene 9(5):1429-1435, 5/1994. PMID: 8152804.
66. Kundra V, Escobedo JA, Kazlauskas A, Kim HK, Rhee SG, Williams LT, Zetter BR. Regulation of chemotaxis by the platelet-derived growth factor receptor-beta. Nature 367(6462):474-476, 2/1994. PMID: 8107807.
67. Yenush L, Kundra V, White MF, Zetter BR. Functional domains of the insulin receptor responsible for chemotactic signaling. J Biol Chem 269(1):100-104, 1/1994. PMID: 8276780.
68. Kundra V, Zetter BR. Molecular mechanisms of metastasis. Intern and Staff Physician, 1994.
69. Kundra V, Dean MF. Transformed SV3T3 cells have a reduced lysosomal compartment and lower levels of enzyme activity than 3T3 cells. Exp Cell Res 189(1):93-99, 7/1990. PMID: 1693341.
70. Singh SP, Ravoori MK, Dixon KA, Han L, Gupta S, Uthamanthil R, Wright KC, Kundra V. Angiotensin II increases gene expression after selective intra-arterial adenovirus delivery in a rabbit model assessed using In vivo SSTR2-based reporter imaging. J Nucl Med. Submitted.

Invited Articles

1. Kundra V. Prostate cancer imaging. Semin Roentgenol 41(2):139-149, 4/2006. PMID: 16697892.
2. Kundra V. Testicular cancer. Semin Roentgenol 39(3):437-450, 7/2004. PMID: 15372756.

Editorials

1. Anvari B, Del Pino P, Kundra V, Parak WJ. Biomimetic and bioinspired materials for applications in biophotonics. J Biomed Opt 19(10):101501, 10/2014. PMID: 25122592.

Abstracts

1. Balachandran A, Bhosale P, Devine C, Morani A, Sagebiel T, Devine C, O Menias c, Kundra V. BRCA Associated Tumors-Not Just Breast and Ovarian Cancer. 100th Asientific Assembly and Annual Meeting, 12/2014.
2. Kundra V. Hereditary Renal Cell Carcinoma. SCBT-MR 2014 Annual Meeting, 10/2014.
3. Gupta S, Kang HC, Ganeshan DM, Bathala T, Kundra V. Diagnostic apporach to hereditary renal cell carcinoma (RCC). Radiological Society of North America 99th Scientific Assembly and Annual Meeting, 12/2013.
4. Rong XJ, Tamm EP, Gershan V, Cody DD, Liu X, Paulson EK, Kundra V. Evaluation the complex relationship of automated tube current modulation, noise index, image noise and phantom size. Radiologic Society of North Americal 99th Scientific Assembly and Annual Meeting, 12/2013.
5. Kundra V, Ravoori M, Han L, Singh S, Dixon RT, Uthamanthil R. In vivo reporter imaging in a large animal pre-clinical model demonstrates that angiotensin II improves gene expression upon intra-arterial adenovirus delivery. Radiological Society of North America 99th Scientific Assembly and Annual Meeting, 12/2013.
6. Bathala T, Morani AC, Kang HC, Gupta S, Ganeshan DM, Kundra V. Oncogenetics of clear cell renal cell carcimoma (ccRCC) in the era of personalized medicine: what radiologist needs to know?. Radiologic Society of North America 99th Scientific Assembly and Annual Meeting, 12/2013.
7. Ganeshan DM, Kundra V, Taggart MW, Barlow JM, Bruining D, Hansel S. Small bowel carcinoid tumors: finding them before they get thto the mesentery and liver. Radiologic Society of North America 99th Scientific Assembly and Annual Meeting, 12/2013.
8. Kundra V. Carcinoid primary and metastatic disease. SCBT-MR Masters in Body Imaging 36th Annual Course, 10/2013.
9. Rong XJ, Jensen CT, Tamm EP, Gershan V, Cody DD, Kiu X, Paulson EK, Kundra V. Evaluating the complex relationship of automated tube current modulation, noise index. image noise and phantom size. SCBT-MR Mastersin Body Imaging 36th Annual Course, 10/2013.
10. Dodge CT, Jensen CT, Tamm EP, Cody DD, Liu X, |Kundra V, Rong XJ. How do inerative reconstruction algorithms affect spatial resolution?. SCBT-MR Masters in Body Imaging 36th Annual Course, 10/2013.
11. Kundra V. Visualizing the prostate gland by MR imaging in young and old mice. World Molecular Imaging Conference 2013, 9/2013.
12. Page L, Kundra V, Rong J,. Investigation of renal CT dose reduction by using model based iterative reconstruction. AAPM 55th Annual Meeting & Exhibition, 8/2013.
13. Guerrero Y, Bahmani B, Singh SP, Vullev VI, Kundra V, Anvari B. Development of anti-HER2 funtionalized optical viral ghosts for targeting ovarian cncer cells. 87th ACS Colloid & Surface Science Symposium, 2013.
14. Guerrero Y, Bhamani B, Jung B, Vullev VI, Kundra V, Anvari B. Targeted imaging of HER-2 over-expressing ovarian cancer cell lineages using viral nanoconstructs doped with indocyanine green. Engineering Conferences International (ECI), Advances in Optics for Biotechnology, Medicine & Surgery XIII, 2013.
15. Tamm EP, Bhosale PR, Wagner-Bartak NA, Le O, Szklaruk J, Kundra V. An Introduction to Using Dual Energy CT for Imaging of pancreatic and hepatic oncology. Radiological Society of North America Annual Meeting, 11/2012.
16. Ganeshan D, Sklaruk J, Kundra V, Kaseb A, Rashid A, Elsayes MK. Cytogenic, histologic and imaging features of fibrolamellar hepatocellular carcinoma: implications for staging diagnosis and treatment based on review of clinical experiences with150 cases. Radiological Society of North America 98th Scientific Assembly and Annual Meeting, 11/2012.
17. Kundra V. Molecular imaging multi-modal approach. Radiological Society of North America 98th Scientific Assembly and Annual Meeting, 11/2012.
18. Kundra V. DWI in prostate cancer. SCBT-MR Masters in Body Imaging 35th Annual Course, 10/2012.
19. Tamm EP, Balachandran A, Bhosale PR, Cody D, \bKundra V. Techniques to Optimize Radiologic Review of Dual Energy CT Studies. Society of Computed Body Tomography and MR Annual Meeting, 10/2012.
20. Kundra V. Molecular imaging: state of the art. East African Oncology and Imaging Conference, 6/2012.
21. Anvari B, Guerro Y, Jung B, Bhamani B, Rao ALN, Singh S, Vullev V, Kundra V. Nano-constructs fabricated from a genome-depleted plant virus and indocyanine green for near infared imaging and phototherapy. 6th International Conference on Bioengineering and Nanotechnology, 2012.
22. Anvari B, Rao ALN, Kundra V, Eager V. Virus-resembling optical nano-materials for intraoperative ovarian cancer imaging. NSF CBET Grantee Conference- Advancing Global Engineering Through Discovery & Innovation, 2012.
23. Ganeshan d, Menias C, Kundra V, Lubner M, Bhosale P, Elsayes K, Shebel H. Imaging of end-stage kidney disease: principles, precautions, and findings. Radiological Society of North America 97th Scientific Assembly and Annual Meeting Program (#LL-URE2535), 11/2011.
24. Elsayes K, Menias C, Wagner-Bartak N, Patnana M, Balachandra A, Devine C, Kundra V. Imaging of the gallbladder wall: a pattern recognition approach on CT and MRI with pathologic correlation. Radiological Society of North America 97th Scientific Assembly and Annual Meeting Program (#LL-GIE2827), 11/2011.
25. Ravoori M, Han L, Singh S, Dixon K, Duggal J, Kundra V, Uthamanthil R, Gupta S, Wright K. Noninvasive assessment of gene transfer and expression by in vivo functional and anatomic imaging in the rabbit VX2 tumor model. Radiological Society of North America 97th Scientific Assembly and Annual Meeting Program (#SSC09-09), 11/2011.
26. Ravoori, MK, Han Lin, Singh SP, Dixon K, Duggal J, Uthamanthil R, Gupta S, Wright K, Kundra V. SSTR2-based reporter imaging in a rabbit VX2 tumor model. J Nucl Med 52(Suppl 1) (#308), 6/2011.
27. Gupta S, Wilder H, Rao ALN, Kundra V, Anvari B. Virus-resembling nano-materials for targeted fluorescence imaging of ovarian cancer cells. NIH Workshop on Optical Diagnostic and Biophotonic Methods from Bench to Bedside, 2011.
28. Costelloe CM, Ma J, Madewell JE, Harrell RK, Bassett RL, Kundra V. Conspicuity of bone lesions on fast dixon-based whole body MRI with diffusion-weighted sequences: estimate of clinical utility per sequence. Proceedings of the 2010 World Molecular Imaging Congress, Mol Imaging Biol 12(Suppl 2):S1161 (#P1002B), 12/2010.
29. Han L, Ravoori MK, Singh SP, Kundra V. Tumor growth inhibition by 111-In octreotide is mediated by the peptide-portion inducing receptor signaling instead of radiation induced injury. Proceedings of the 2010 World Molecular Imaging Congress, Mol Imaging Biol 12(Suppl 2):S1058 (#P0525B), 12/2010.
30. Singh S, Han L, Ravoori M, Harris D, Estrov Z, Kundra V. Long-term stem cell trafficking/engraftment imaging is enabled by a human somatostatin receptor type-2 (hSSTR2) mutant with the desirable features of being muted in altering stem cell signaling and function. Radiological Society of North America 96th Scientific Assembly and Annual Meeting Program (#SSG09-09), 11/2010.
31. Bhosale PR, Klekers AR, Balachandran A, Kundra V. MRI for locally advanced prostate cancer: what does a surgeon want to know?. Radiological Society of North America 96th Scientific Assembly and Annual Meeting Program (#LL-URE4175), 11/2010.
32. Tamm EP, Dunnington JS, Bhosale PR, Vikram R, Kaur H, Szklaruk J, Kundra V. Quality improvement in CT: a program for modifying/improving abdominal/pelvic CT imaging protocols while maintaining throughput in a large clinical practice. Radiological Society of North America 96th Scientific Assembly and Annual Meeting Program (#LL-PPE4097), 11/2010.
33. Tamm EP, Rong JX, Cody D, Ernst RD, Fitzgerald NE, Kundra V. Review of a program for dose reduction for MDCT. Radiological Society of North America 96th Scientific Assembly and Annual Meeting Program (#LL-PPE-MO2B), 11/2010.
34. Bhosale PR, Prativadi RG, Balachandran A, Vikram R, Wei W, Devine CE, Kundra V, Rohren EM. What is the clinical significance of FDG uptake in the prostate in a patient undergoing a PET/CT?. Radiological Society of North America 96th Scientific Assembly and Annual Meeting Program (#LL-NMS-MO1B), 11/2010.
35. Singh S, Han L, Ravoori M, Solis L, Ji L, Wistuba I, Kundra V. SSTR2-based reporters for assessing gene transfer into non-small cell lung cancer. J Nucl Med 51(Suppl 2) (#1182), 5/2010.
36. Silva, G, Marini FC, Zheng Y, Baimbridge F, Quan X, Jackson J, Paolillo V, Mukhopadhyay U, Alauddin MM, Borne A, Uthamanthil R, Brammer D, Najjar AM, Soghomonyan S, Jeong H-J, Rios JM, Mawlawi O, Pan T, Stafford J, Kundra V, Li C, Shpall E, Perin E, Gelovani JG. Long-term monitoring of persistence, migration and differentiate of HSV1-tk expressed mesenchymal stem cells in an ischemia-reperfusion porcine model with 18F-FEAU PET/CT and MRI. Proceedings of the 2009 World Molecular Imaging Congress, Mol Imaging Biol 12(Suppl 1):S224-S225 (#J475), 2/2010.
37. Rampurwala M, Ravoori M, Wei W, Johnson V, Vikram R, Kundra V. Negative contrast enhancement enables visualization of intraperitoneal tumors in mice using CT. Proceedings of the 2009 World Molecular Imaging Congress, Mol Imaging Biol 12(Suppl 1):S377 (#J792), 2/2010.
38. Singh SP, Han L, Ravoori M, Harris D, Estrov Z, Kundra V. In vivo imaging of long term stem cell trafficking/engraftment is enabled by a human somatostatin receptor type-2 (hSSTR2) mutant that has the desirable features of being muted in altering stem cell signaling and function. J Nucl Med 50(Suppl 2) (#633), 5/2009.
39. Ma J, Costelloe C, Madewell JE, Hortobagyi G, Green M, Cao G, Sun F, Kundra V. Multisequence and multiplanar whole body MRI for detection of cancer metastases. Proc Intl Soc Mag Reson Med 17:224, 4/2009.
40. Ng CS, Bankson JA, Kundra V, Waterton JC, Jackson, EF. Reproducibility and cross-validation of DCE-MRI and DCE-CT perfusion parameters in a rat tumor model. Proc Intl Soc Mag Reson Med 17:4228, 4/2009.
41. Le-Petross H, Kundra V, Szklaruk J, Wei W, Andreopoulou E, Ma J. Fat suppression for breast MRI improves by fast 3D dual echo Dixon technique. AJR Am J Roentgenol 192(5 Suppl) (#E019), May, 2009.
42. Coleman RL, Kamat A, Iyer R, Kundra V, Garcia M, Jaffe RB, Sood AK. Phase I and pharmacokinetic study of the novel VEGF directed fusion protein, aflibercept in combination with docetaxel in women with recurrent ovarian, fallopian tube and primary peritoneal cancer. J Clin Oncol 27(15s) (#5549), 2009.
43. Singh SP, Ravoori M, Han L, Yang D, Kundra V. Quantifying in vivo gene transfer. J Nucl Med 49(Suppl 1):26P (#104), 5/2008.
44. Li Z-G, Navone N, Yang J, Liu J, Mathew P, Starbuck M, Zurita A, Sikes C, Multani A, Efstathiou E, Lopez A, Wang J, Fanning T, Prieto V, Kundra V, Troncoso P, Raymond A, Lin S-H, Vazquez E. Androgen receptor-negative human prostate cancer cells induce osteogenesis through FGF9-mediated mechanisms. 99th AACR Annual Meeting Abstracts (#1612), 4/2008.
45. Singh SP, Han L, Ravoori M, Estrov Z, Kundra V. A human somatostatin receptor type-2 mutant with the desirable features of being muted in altering stem cell signaling and function can serve as a reporter of long term stem cell trafficking/engraftment. World Molecular Imaging Congress, 2008.
46. Gupta S, Wright K, Dixon K, Van Pelt CS, Kauffman C, Kundra V. Hepatic arterial embolization with doxorubicin loaded superabsorbent polymeric microspheres in an animal model. J Vasc Interv Radiol 19(2 Suppl 1):S127 (#345), 2008.
47. Han L, Singh SP, Ravoori M, Wistuba I I, Ji L, Kundra V. Imaging gene transfer into non-small cell lung cancer using somatostatin receptor type 2-based reporters. World Molecular Imaging Congress, 2008.
48. Verma R, Singh SP, Murthy R, Kundra V. In vitro activation of radiation sensitive promoter (Egr-1) via β-radiation from 90Y microspheres. J Vasc Interv Radiol 19(2 Suppl 1):S47 (#120), 2008.
49. Vikram R, Yang T, Kundra V. The value of CT scan of abdomen and pelvis in patients with treated colorectal cancer in the setting of an undetectable carcinoembryonic antigen (CEA). AJR Am J Roentgenol 190(4 Suppl) (#255), Apr, 2008.
50. Vikram R, Yang T, Kundra V. Value of CT (abd & pelvis) in patients with treated colorectal cancer and undetectable carcinoembryonic antigen (CEA). Abdominal Radiology Course Syllabus, 2008.
51. Han L, Yang D, Kundra V. Signaling can be uncoupled from imaging of the somatostatin receptor type-2. Mol Imaging 47(Suppl 1):108P, Nov-Dec, 11/2007. PMID: 18053413.
52. Klostergaard J, Auzenne E, Ghosh S, Khodadadian M, Rivera B, Farquhar D, Price R, Ravoori M, Kundra V, Freedman R. CD44-targeted hyaluronic acid-paclitaxel (HA-TXL) copolymer for treatment of human ovarian carcinoma xenografts. AACR-NCI-EORTC International Conference Abstracts (#C291), 10/2007.
53. Ravoori M, Kim TJ, Landen CN, Kamat A, Han LY, Lu C, Lin YG, Merritt W, Spannuth W, Gershenson DM, Coleman RL, Sood AK, Kundra V. Efficacy and antitumor effects of AVE8062 in a mouse model of an orthotopic ovarian cancer. J Nucl Med 48(Suppl 2):345P (#1494), 5/2007.
54. Ma J, Costello C, Kundra V, Zhou Y, Green M, Hortobagyi GN, Madewell JE. Single session whole body T2-weighted and T1-weighted MRI (both with and without fat suppression). Proc Intl Soc Mag Reson Med 15:528 (#2724), 5/2007.
55. Kamat A, Han L, Armaiz-Pena G, Ravoori M, Kim TJ, Lu C, Thaker P, Lin Y, Merritt W, Kundra V, Gershenson D, Lutgendorf S, Cole S, Sood A. Chronic stress alters the functional characteristics of tumor vasculature in ovarian carcinoma in female nude mice. 98th AACR Meeting Abstracts (#5595), 4/2007.
56. Hennessy BT, Lu Y, Poradosu E, Yu Q, Yu S, Hall H, Ravoori M, Carey M, Gonzalez-Angulo AM, Birch R, Henderson IC, Kundra V, Mills GB. Quantified pathway inhibition as a pharmacodynamic marker facilitating optimal targeted therapy dosing: proof of principle with the AKT inhibitor perifosine. Ovarian SPORE Meeting, 2007.
57. Han L, Yang D, Kundra V. Signaling can be uncoupled from imaging of the somatostatin receptor type 2. J Nucl Med 47(Suppl 1):108P (#309), 5/2006.
58. Bankson J, Ji L, Ravoori M, Han L, Kundra V. Echo-plannar MRI for rapid assessment of intrathoracic tumors in murine models of lung cancer. Society of Molecular Imaging Annual Meeting, 2006.
59. Kim TJ, Ravoori M, Landen CN, Lu C, Kamat A, Han LY, Kundra V, Sood AK. Effects of AVE8062 plus docetaxel on tumor growth in an orthotopic model of ovarian cancer. Proc Amer Assoc Cancer Res 47 (#956), 2006.
60. Lu Y, Su JD, Jy S, Hall H, Ravoori M, Kundra V, Miller T, Patterson M, Garlich JR, Mills GB. Identification of molecular markers for selection of patients likely to respond and pharmacodynamic markers of delivery of biologically relevant dose and early response to a novel phosphatidylinositol 3-kinase PI3K inhibitory prodrug, SF1126. Proc Amer Assoc Cancer Res 47 (#LB-274), 2006.
61. Ravoori M, Sikes C, Navone NM, Kundra V. Image-based analysis of mineralized bone in a mouse model of prostate cancer involving the skeleton. Inter-Prostate SPORE Meeting, 2006.
62. Bankson JA, Ji L, Kundra V. Echo-planar imaging improves staging of murine model of lung cancer. Proc Intl Soc Mag Reson Med 13:2046, 4/2005.
63. Wu G, Uno F, Arlinghaus R, Kundra V, Minna JD, Roth JA, Ji L. Inactivation of c-able and c-kit activities and inhibition of SCLC cell growth by a combination treatment with FUS1-nanoparticle and Gleevac in vitro and in vivo. Proc Amer Assoc Cancer Res 46 (#5021), 4/2005.
64. Wu G, Deng W, Kundra V, Fang B, Roth JA, Ji L. A novel synthetic hTERT-Mini-CMV chimera promoter-driven tumor-selective and high-efficiency expression of transgene for systemic cancer gene therapy. Proc Amer Assoc Cancer Res 46 (#3358), 2005.
65. Johnson E, Kundra V, Crombrugghe B, Zhou X, Cody DD. Dependency of trabecular characteristics on CT voxel size. American Society for Bone and Mineral Research Annual Meeting, 2005.
66. Bankson J, Cody C, Ma J, Navone N, Ng C, Price R, Kundra V. Imaging the natural history of prostate cancer involving bone in a mouse model. InterProstate SPORE Meeting, 2004.
67. Yang D, Han L, Kundra V. Following gene transfer by functional and anatomic imaging. Society of Nuclear Medicine Annual Meeting Proceedings, 2003.
68. Erwin WD, Wendt RE III, Kundra V. Sensitivity of planar and SPECT imaging of 111In with a small animal gamma-camera. Society of Nuclear Medicine Annual Meeting Proceedings, 2003.

Book Chapters

1. Kundra V. Introduction to Molecular Imaging. In: In Drug Delivery Applications of Noninvasive Imaging. Wiley, 2013.
2. Kundra V, Matin SF, Kuban DA. Prostate cancer. In: Oncologic Imaging, A Multidisciplinary Approach. Elsevier Saunders, 2012.
3. Kundra V. Clinical potential of gene expression imaging. In: Molecular Imaging in Oncology. Ed(s) M Pomper, J Gelovani. Informa Press: New York, 429-442, 2008. ISBN: 0849374170.
4. Kundra V, Mawlawi O. PET imaging in genomic medicine. In: Genomic and Personalized Medicine. Ed(s) H Willard, G Ginsburg. Elsevier: Amsterdam; Boston, 461-469, 2008.
5. Kundra V, Schellingerhout D, Jackson EF. Targeted and functional imaging. In: Targeted Cancer Therapy. Ed(s) R Kurzrock, M Markman. Humana Press: Totowa, 335-360, 2008. ISBN: 978-1-60327-423-4.
6. Channock SJ, Kundra V, Johnson FL, Singer MD. The other side of the bed: what caregivers can learn from listening to patients and their families. In: Principles and Practice of Pediatric Oncology, 5th. Ed(s) PA Pizzo, DG Poplack. Lippincott Williams & Wilkins: Philadelphia, 1446-1465, 2006.
7. Channock SJ, Kundra V, Johnson FL, Singer MD. The other side of the bed: what caregivers can learn from listening to patients and their families. In: Principles and Practice of Pediatric Oncology, 4th. Ed(s) PA Pizzo, DG Poplack. Lippincott Williams & Wilkins: Philadelphia, 1393-1410, 2002.
8. Channock SJ, Kundra V, Johnson FL, Singer MD. The other side of the bed: what caregivers can learn from listening to patients and their families. In: Principles and Practice of Pediatric Oncology, 3rd. Ed(s) PA Pizzo, DG Poplack. Lippincott-Raven: Philadelphia, 1157-1169, 1997.
9. Channock SJ,Kundra V, Johnson FL, Singer MD. The other side of the bed: what caregivers can learn from listening to patients and their families. In: Principles and Practice of Pediatric Oncology, 2nd. Ed(s) PA Pizzo, DG Poplack. J.B. Lippincott: Philadelphia, 1157-1169, 1993.

Grant & Contract Support

Title: Hyperpolarized 13C-Pyruvate MRS in Prostate Cancer: Benchmark for detecting prostate cancer in patients, link to biology, functionalizing imaging and biology
Funding Source: CABI
Role: Co-Principal Investigator
Duration: 5/2015
 
Title: Nanoparticle Guidance for Diagnosing and Surgically Removing Ovarian Cancer
Funding Source: National Science Foundation (NSF)
Role: Co-Principal Investigator
Duration: 3/1/2014 - 2/28/2017
 
Title: In vivo Metabolic Imaging of Renal Cell Carcinoma
Funding Source: UT MD Anderson Cancer Center Kidney Cancer Research Program
Role: Principal Investigator
Duration: 4/1/2013 - 12/31/2015
 
Title: Clinical Translation of Therapeutic siRNA in Solid Malignancies
Funding Source: Cancer Prevention & Research Institute of Texas (CPRIT)
Role: Co-Investigator
Principal Investigator: Coleman R
Duration: 12/1/2011 - 11/30/2015
 
Title: Virus-resembling optical nano-materials for ovarian cancer imaging and phototherapy
Funding Source: National Science Foundation (NSF)
Role: Co-Principal Investigator
Duration: 8/1/2011 - 7/31/2014
 
Title: Simultaneous Multiple-Animal SPECT Imaging
Funding Source: NIH/NCI
Role: Collaborator
Principal Investigator: Y Shao
Duration: 7/1/2011 - 6/30/2014
 
Title: Personalizing Nanoparticle Therapy
Funding Source: National Institutes of Health - DHHS
Role: Principal Investigator
Duration: 3/1/2011 - 2/28/2016
 
Title: The University of Texas M.D. Anderson Cancer Center SPORE in Ovarian Cancer: Targeting D114-Notch Signaling in Ovarian Cancer
Funding Source: NIH/NCI
Role: Collaborator
Principal Investigator: R Bast
Duration: 9/15/2010 - 8/31/2015
 
Title: Targeting DII4-Notch Signaling in Ovarian Cancer
Funding Source: National Cancer Institute - DHHS
Role: Co-Investigator
Duration: 9/15/2010 - 8/31/2015
 
Title: Chemopreventive Effect of Fish Oil Derived EPA in Lung Cancer
Funding Source: NIH/NCI
Role: Co-Investigator
Principal Investigator: P Yang
Duration: 7/1/2010 - 4/30/2014
 
Title: Imaging the prostate gland and otrhotopic prostate cancer
Funding Source: NIH/NCI
Role: Collaborator
Principal Investigator: Logothetis C
Duration: 12/1/2009 - 12/31/2013
 
Title: MD Anderson Cancer Center Prostate SPORE
Funding Source: NIH/NCI
Role: Project Leader
Principal Investigator: C Logothetis
Duration: 9/2/2009 - 12/31/2013
 
Title: Image Based Evaluation of Tumor Targeting and Efficacy of Gene Therapy
Funding Source: NIH/NCI
Role: Principal Investigator
Duration: 1/15/2009 - 12/31/2012
 
Title: Stem Cell Engraftment
Funding Source: NIH/NCI
Role: Principal Investigator
Duration: 2009 - 2014
 
Title: UPRCCC/MDACC Partnership for Excellence in Cancer Research: Synthesis and Pre-clincal Evaluation of Targeted, Iron-Based MRI Contrast Agents to Enhance Ovarian Cancer Detection and Treatment Scheduling
Funding Source: NIH/NCI
Role: Collaborator
Principal Investigator: R DuBois
Duration: 9/29/2008 - 8/31/2013
 
Title: Sweet Gum Extract and Late Stage Prostate Cancer
Funding Source: NIH
Role: Collaborator
Principal Investigator: P Yang
Duration: 9/15/2008 - 6/30/2011
 
Title: Prostate Cancer Models Linking Molecular Signature to Clinical Stage and Therapeutic Response
Funding Source: Prostate Cancer Foundation
Role: Collaborator
Principal Investigator: N Navone
Duration: 2008 - 2011
 
Title: Nanoparticles for Treatment of Lung Cancer
Funding Source: NIH, SBIR
Role: Collaborator
Principal Investigator: S Chada
Duration: 2008 - 2010
 
Title: Image-Guided Delivery and Image-Guided Evaluation of Target and Non-Target Tissue
Funding Source: NIH/NCI
Role: Principal Investigator
Duration: 8/30/2007 - 8/31/2011
 
Title: Tumor and PTK-Targeted Therapy by FUS1 and PTK Inhibitors
Funding Source: NIH
Role: Collaborator
Principal Investigator: L Ji
Duration: 6/1/2007 - 5/31/2011
 
Title: Following DNA Vaccine Expression and T-Cell Trafficking to Lymphoma
Funding Source: UT-MDACC Center for Targeted Therapy (CTT) Disease-Specific Grant Program
Role: Principal Investigator
Duration: 2007 - 2009
 
Title: Objective Evaluation of DCE-CT and DCE-MRI in Assessing Tumor Perfusion and Permeability Changes with AZ Drugs in the Angiogenesis Biological Effect Area in an Animal Model
Funding Source: AstraZeneca
Role: Collaborator
Principal Investigator: R Bast
Duration: 10/5/2006 - 7/1/2010
 
Title: Alliance of Nanohealth Seed Grant Projects - DOD: On-Command Control of Blood Pool Residence Time for Nanoparticle-Based Molecular Imaging
Funding Source: University of Texas Health Science Center - Houston
Role: Project Leader
Principal Investigator: R Bast
Duration: 9/29/2006 - 10/28/2009
 
Title: Medical Physics Training Grant for Image-Guided Therapy Research
Funding Source: NIH/NCI
Role: Collaborator
Principal Investigator: EF Jackson
Duration: 8/4/2006 - 7/31/2012
 
Title: Whole Body MRI for Detecting Breast Cancer Metastases
Funding Source: Susan G. Komen Breast Cancer Foundation
Role: Collaborator
Principal Investigator: J Ma
Duration: 5/1/2006 - 4/30/2009
 
Title: SPORE in Ovarian Cancer: Imaging Ovarian Cancer Specific Gene Expression In Vivo
Funding Source: NIH/NCI
Role: Project Leader
Principal Investigator: R Bast
Duration: 3/16/2006 - 8/31/2010
 
Title: The University of Texas M.D. Anderson Cancer Center SPORE in Prostate Cancer: Imaging the Natural History of Prostate Cancer Involving Bone in a Mouse Model
Funding Source: NIH/NCI
Role: Program Leader
Principal Investigator: C Logothetis
Duration: 6/1/2005 - 12/31/2007
 
Title: Identification and Validation of Methods to Determine Delivery of Biologically Relevant Dose of Perifosine to Patient Tumors
Funding Source: Keryx
Role: Co-Investigator
Principal Investigator: G Mills
Duration: 12/31/2004 - 12/31/2006
 
Title: Identification and Validation of Methods to Determine Delivery of Biologically Relevant Dose of LY317615 and Its Metabolite LY492403 to Patient Tumors
Funding Source: Ely Lilly and Company
Role: Co-Investigator
Principal Investigator: G Mills
Duration: 12/17/2004 - 12/16/2006

Last updated: 8/5/2015